𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome

✍ Scribed by Charles G. Moertel; Larry K. Kvols; Joseph Rubin

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
371 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estrogen receptor protein in malignant c
Estrogen receptor protein in malignant carcinoid tumor a report of 2 cases
✍ Albert A. Keshgegian; James E. Wheeler πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 1 views

Two cases of metastatic malignant carcinoid tumor in elderly women contained significant amounts of estrogen receptor (19 and 32 femtomoledmg protein) as shown by Scatchard-plot analysis of a dextran-coated charcoal assay, inhibition of binding by an estrogen analog (67 and 63%) and highaffinity bin

Carcinoid tumors of the extrahepatic bil
Carcinoid tumors of the extrahepatic bile duct : A rare cause of malignant biliary obstruction
✍ Ronald S. Chamberlain; Leslie H. Blumgart πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 243 KB πŸ‘ 2 views

## BACKGROUND. Carcinoid tumors of the extrahepatic bile duct are rare and account for 0.2-2% of all gastrointestinal carcinoids. Similar to other tumors of the bile duct, these lesions are difficult to diagnose preoperatively and nearly impossible to distinguish from cholangiocarcinoma. ## METHOD

Incidence and morbidity of cholelithiasi
Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors
✍ Michael C. Trendle; Charles G. Moertel; Larry K. Kvols πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

## Background: Octreotide, a long-acting somatostatin analogue, has demonstrated clinical utility in patients with carcinoid syndrome and malignant islet cell tumors of the pancreas. prior studies have reported a greater than expected incidence of cholelithiasis in patients treated with octreotide